Login

MicroStrategy CEO Michael Saylor shares insights on the future of the company. 00:10:00

Share On Facebook Share On Twitter

Saylor has served as Executive Chairman since August 2022. 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Financial Planning Basics with Centry Financial Advisors | Janice Cackowski, President, Centry Financial Advisors, LLC.
00:10:00
Disruption: Insights from Jon Gray and Ken Griffin | Perspectives from Global Financial Leaders’ Investment Summit
00:10:00
Market History & Financial Planning with George Smith | George Smith, co-CEO and Chief Investment Officer of Smith Bruer Advisors
00:10:00
Dan Goldberg, president and CEO of Telesat, discusses leadership and industry insights as a former recipient of the OBJ-Ottawa Board of Trade CEO of the Year award.
00:10:00
Tim Chen, CEO of NerdWallet, appears on 'Closing Bell Overtime' to discuss the company's new credit-building card, a significant stock surge, and more.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Dr. Preston Cherry on Personality Traits and Risk Management | Daniel Yerger - President of MY Wealth Planners
00:10:00
Finding the Best Investment Strategy for You | Adam Taylor, CEO, Taylor Financial.
00:10:00
Empowering Investors: State Street Global Advisors Expands Investor Voting Choice Program | Yie-Hsin Hung, CEO , State Street Global Advisors.
00:10:00
Advancing Gold Exploration: Banion's Strategic Developments in the Yukon Territory
00:10:00
Italian Banks' NPL Crisis: Fabrizio Pagani of Muzinich & Co. on Economic Outlook and Challenges
00:10:00
Khadija Ajmi, Environmental Engineer at Greenthesis Group's Remediation Office, discusses environmental initiatives, alongside an interview with Alberto Rossi, CIO.
00:10:00
Onshore vs. Offshore: Francois Verlaine’s Insights on Fund Structures | MD, Standard Chartered

© 2026 Nehu